Professional Documents
Culture Documents
Biophysics
Biophysics
[Date]
Subject- Biophysics
Introduction-
Plasmapheresis is a medical procedure designed to remove plasma from the blood. During a
plasma exchange, unhealthy plasma is swapped for healthy plasma or a plasma substitute,
before the blood is returned to the body. The blood vessels contain plasma. It is a fluid made
up of blood cells, platelets, and essential nutrients. During plasmapheresis, blood is removed
and separated into these parts by a machine. Plasmapheresis can also refer to when plasma is
removed from the body to be donated.
History Of Plasmapheresis-
On 15 February 2013 we celebrated the 100-year anniversary of the world's first successful
experimental plasmapheresis. Scientific research projects in this field were carried out by the
Department of Infectious Disease, Russian Imperial Medical Surgical Academy located in
Saint-Petersburg. Doctor of Medical Sciences and Professor Vadim A. Yurevich was a
Principal Investigator for this research, which in 1913 resulted in the discovery of a new way
of treatment. The results were published in Russki Vratch (Russian Physician) Journal no. 18
(1914) - V.A. Yurevich and N.K. Rosenberg "For the Question Regarding Washing of Blood
Outside of the Body and the Vitality of Red Blood Cells". There was no terminology offered
for this medical innovation at that time. Plasma removal was performed not solely, but in
combination with washing of blood cells returned to the patient. Nowadays this combination
is still considered to be more effective than separate plasmapheresis. According to the
published experimental protocols this new treatment was done on 15 February (2 February on
the Julian Calendar or "old style"). One year later in 1914 a famous researcher, John Abel and
Coauthors, repeated a separate plasma removal treatment with re-transfusion of the blood
cells and suggested the term "plasmapheresis", which is now official.
Therapeutic Machine
Advantages-
1. More selective than Plasma Exchange.
2. Returns purified plasma to the patient.
3. Minimal loss of patient’s own desirable non-pathogenic substances.
4. Minimal Albumin loss.
5. Minimal substitution fluid required - no FFP.
6. Minimal risk of infection from substitution fluids.
7. Reduces possible protein allergy to substitution fluid.
Disadvantages-
1. Semi-selective.
2. Some “valuable” components of similar size and Molecular Weight to pathogen may
also be lost.